🟢 Neumora Therapeutics is trading 5.6% up today as broader biotech-sector gains

Neumora Therapeutics is trading 5.6% up at $1.41 after opening higher on September 2, 2026, amid broad biotechnology-sector gains.

• The sector’s XBI ETF is up 2.75%, supported by patent-related news and renewed positive industry momentum.
• No clear company-specific announcement has been identified for September 2, 2026.
• Neumora’s latest investor-relations release remains its August 14, 2026, second-quarter update.